These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35318844)

  • 1. [Study of the efficacy and safety of sequential use of the drugs Mexidol and Mexidol FORTE 250 in the treatment of stroke].
    Karpov SM; Morozova MY; Muravyov KA; Vyshlova IA; Kantemirova FS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3. Vyp. 2):59-62. PubMed ID: 35318844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The efficacy and safety of Mexidol Forte 250 as part of long-term sequential therapy in patients with carotid stroke].
    Strelnikova IA; Svetkina AA; Androfagina OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):54-58. PubMed ID: 32307431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurometabolic therapy of mild cognitive impairment in patients with chronic cerebral ischemia].
    Antipenko EA; Shulyndin AV; Belyakov KM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(3):42-51. PubMed ID: 38529862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness and safety of mexidol forte 250 in the sequential therapy in patients with chronic ischemia].
    Kataeva NG; Zamoshchina TA; Svetlik MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(11):59-63. PubMed ID: 33340299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of a cohort single-center randomized study of the modulating effect of the drug Mexidol in the rehabilitation of patients who suffered acute cerebral insufficiency].
    Belkin AA; Belkin VA; Vasilchenko IE; Pinchuk EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):108-117. PubMed ID: 38676685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The trial of the efficacy and safety of sequential therapy with Mexidol forte 250 in acute and early recovery stages of hemispheric ischemic stroke].
    Loskutnikov MA; Domashenko MA; Vakin TM; Trushina IA; Konstantinov VI; Proskuryakova OS; Shchukina EP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(10):22-26. PubMed ID: 33244953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)].
    Fedin AI; Zakharov VV; Tanashyan MM; Chukanova EI; Madzhidova EN; Shchepankevich LA; Ostroumova OD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):7-16. PubMed ID: 34932280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
    Kutashov VA; Ulyanova OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):89-92. PubMed ID: 32207723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy and safety study of Mexidol and Mexidol FORTE 250 in patients with chronic cerebral ischemia].
    Shchepankevich LA; Nikolaev YA; Taneeva EV; Pervuninskaya MA; Shchepankevich MS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10):32-37. PubMed ID: 34874652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improving the effectiveness of pharmacotherapy in comorbid patients with chronic cerebral ischemia on an outpatient basis].
    Vizilo TL; Arefieva EG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3):51-55. PubMed ID: 36946397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain].
    Chukanova EI; Chukanova AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):39-45. PubMed ID: 31626217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of the sequential use of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
    Abramenko YV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):59-64. PubMed ID: 32307432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of mexidol across age groups in the acute and early recovery stages of hemispheric ischemic stroke (results of additional sub-analysis of a randomized double blind multicenter placebo-controlled study, in parallel groups trial EPICA)].
    Stakhovskaya LV; Mkhitaryan EA; Tkacheva ON; Ostroumova TM; Ostroumova OD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8. Vyp. 2):49-57. PubMed ID: 33016677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of Mexidol in patients with chronic brain ischemia and cognitive impairment of different age groups (results of sub-analysis of the international multicenter, randomized, double-blind, placebo-controlled study of sequential therapy in patients with chronic brain ischemia MEMO)].
    Zakharov VV; Tkacheva ON; Mkhitaryan EA; Fedin AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11. Vyp. 2):73-80. PubMed ID: 36412160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)].
    Stakhovskaya LV; Shamalov NA; Khasanova DR; Melnikova EV; Agafiina AS; Golikov KV; Bogdanov EI; Yakupova AA; Roshkovskaya LV; Lukinykh LV; Lokshtanova TM; Poverennova IE; Shepankevich LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3. Vyp. 2):55-65. PubMed ID: 28665371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities of improving the effectiveness of therapy in patients with chronic cerebral ischemia against the background of COVID-19].
    Kovalchuk VV; Ershova II; Molodovskaya NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3. Vyp. 2):60-66. PubMed ID: 33908234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of antioxidant treatment with mexidol forte in 250 patients with chronic cerebral venous insufficiency].
    Chukanova EI; Chukanova AS; Mamaeva KI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3):57-63. PubMed ID: 33834719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of Mexidol in patients with mild (moderate) cognitive impairment: results of a meta-analysis].
    Zakharov VV; Vakhnina NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(1):82-88. PubMed ID: 38261288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of Mexidol in the correction of postcovid syndrome in patients with chronic cerebrovascular diseases].
    Kuznetsova EB; Salina EA; Kuznetsov NS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(5):117-122. PubMed ID: 37315250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of patients with ishemic stroke in the vertebral-basilar system in acute period: experience of using the neuroprotective drug Mexidol].
    Goncharova ZA; Chernikova IV; Nazarova VA; Tolmacheva VV; Ovsepian KG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(2):78-84. PubMed ID: 38465813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.